Brain atrophy in multiple sclerosis: impact of lesions and of damage of whole brain tissue

Abstract

Introduction: In multiple sclerosis (MS), brain atrophy measurement on magnetic resonance imaging (MRI) reflects overall tissue loss, especially demyelination and axonal loss. We studied which factor contributes most to the development of brain atrophy: extent and severity of lesions or damage of whole brain tissue (WBT). Methods: Eighty-six patients with MS [32 primary progressive (PP), 32 secondary progressive (SP)] and 22 relapsing-remitting (RR) were studied. MRI included T1- and T2-weighted imaging to obtain hypointense T1 lesion volume (T1LV) and two brain volume measurements: 1) the parenchymal fraction (PF; whole brain parenchymal volume/intracranial volume) as a marker of overall brain volume, and 2) the ventricular fraction (VF; ventricular volume/intracranial volume) as a marker of central atrophy. From magnetization transfer ratio (MTR) histograms, the relative peak height (rHp) was derived as an index of damage of WBT (a lower peak height reflects damage of WBT). Results: Multiple linear regression analysis revealed that damage of WBT explains most of the variance of PF (standardized coefficient b=0.59, p <0.001 for WBT and b= −0.19, p <0.05 for T1LV). These findings are independent of disease phase; even in RR patients, damage of WBT plays a dominant role in explaining the variance in overall brain volume. By contrast, the variance in VF is explained by both T1LV and damage of WBT (standardized coefficient b =0.43, p<0.001 for T1LV and b = −0.38, p <0.001 for WBT). Conclusion: This study shows that overall brain volume (PF) is best explained by damage of WBT, supporting the significance of nonfocal pathology in MS in producing tissue loss. Central atrophy (VF) is determined by both lesion volume and damage of WBT. Our results underline the importance of nonfocal pathology even in the early (RR) phase of the disease.

Keywords

brain atrophy histogram analysis lesion volume magnetic resonance imaging magnetization transfer ratio multiple sclerosis whole brain tissue

Get full access to this article

View all access options for this article.

References

Trapp BD , Peterson J , Ransohoff RM , Rudick R , Mork S , Bo L. Axonal transection in the lesions of multiple sclerosis . N Engl J Med 1998; 338: 278-285 .

van Waesberghe JH , Kamphorst W , De Groot CJ , et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability . Ann Neurol 1999; 46: 747-754 .

Bruck W , Bitsch A , Kolenda H , Bruck Y , Stiefel M , Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology . Ann Neurol 1997; 42: 783-793 .

Barkhof F , McGowan JC , van Waesberghe JH , Grossman RI. Hypointense multiple sclerosis lesions on T1-weighted spin echo magnetic resonance images: their contribution in understanding multiple sclerosis evolution . J Neurol Neurosurg Psychiatry 1998; 64(Suppl 1): S77-S79 .

Paty DW , Li DK. Importance of magnetic resonance imaging and gadolinium enhancement . Ann Neurol 1996; 40: 951-953 .

van Walderveen MA , Barkhof F , Hommes OR , et al. Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images . Neurology 1995; 45: 1684-1690 .

van Walderveen MA , Kamphorst W , Scheltens P , et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis . Neurology 1998; 50: 1282-1288 .

Fu L , Matthews PM , Destefano N , et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis . Brain 1998; 121(Part 1): 103-113 .

Moffett JR , Namboodiri MA , Cangro CB , Neale JH. Immunohistochemical localization of N-acetylaspartate in rat brain . Neuro-Report 1991; 2: 131-134 .

10.

van Walderveen MA , Barkhof F , Pouwels PJ , van Schijndel RA , Polman CH , Castelijns JA. Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy . Ann Neurol 1999; 46: 79-87 .

11.

[published erratum appears in Radiology 1992; 183: 878-878 ].

12.

Dousset V , Brochet B , Vital A , et al. Lysolecithin-induced demyelination in primates: preliminary in vivo study with MR and magnetization transfer . Am J Neuroradiol 1995; 16: 225-231 .

13.

Rovaris M , Bozzali M , Rodegher M , Tortorella C , Comi G , Filippi M. Brain MRI correlates of magnetization transfer imaging metrics in patients with multiple sclerosis . J Neurol Sci 1999; 166: 58-63 .

14.

Tortorella C , Viti B , Bozzali M , et al. A magnetization transfer histogram study of normal-appearing brain tissue in MS . Neurology 2000; 54: 186-193 .

15.

Phillips MD , Grossman RI , Miki Y , et al. Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis . Am J Neuroradiol 1998; 19: 1055-1060 .

16.

Lublin FD , Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey . Neurology 1996; 46: 907-911 .

17.

Kalkers NF , Bergers L , Castelijns JA , Polman CH , Barkhof F. Brain atrophy measurements in multiple sclerosis: intra- and inter-observer reproducibility of 2 methods . J Neurol 2000; 247(Suppl 1): 111-111 (Abstract).

18.

Kalkers NF , Hintzen RQ , van Waesberghe JH , et al. Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy . J Neurol Sci 2001; 184: 155-162 .

19.

Paolillo A , Pozzilli C , Gasperini C , et al. Brain atrophy in relapsing -remitting multiple sclerosis: relationship with `black holes,’ disease duration and clinical disability . J Neurol Sci 2000; 174: 85-91 .

20.

Simon JH. From enhancing lesions to brain atrophy in relapsing MS . J Neuroimmunol 1999; 98: 7-15 .

21.

Brex PA , Jenkins R , Fox NC , et al. Detection of ventricular enlargement in patients at the earliest clinical stage of MS . Neurology 2000; 54: 1689-1691 .